Congress of the Aesthetic Medicine Industry

What we call personalization today is just the beginning. The true future of skin therapy begins where the standard protocol ends—at the cellular level. In this lecture, we will present a modern, integrated model of skin therapy based on precise imaging diagnostics, biological analysis, and the use of advanced active ingredients. We will discuss the mechanisms of action of, among others, NAD+, exosomes, and peptides in the context of cellular regeneration, as well as their role in creating personalized therapeutic protocols. A key element will be demonstrating how to combine in-clinic therapy with individually tailored at-home skincare, creating a continuous, biologically coherent process of skin regeneration.

The immense popularity of weight-loss medications means that we are increasingly seeing issues related to a loss of skin firmness and volume in the face and body during rapid weight loss. This lecture presents effective strategies and modern technologies that support skin regeneration and harmonious body contouring during intensive weight loss.

Modern cosmetology today works with biology, not against it. During the lecture, we will demonstrate how M’onduniq technologies—the thulium laser, LED lamp, and GENEXEM exosomes—work together to support the skin’s regenerative processes. This is a practical look at combination therapies, treatment safety, and building a clinic’s competitive edge in the high-tech segment.

The lecture introduces the STG brand as an integrated model for creating clinics—from business concept and location selection, through design, construction, and equipment, to launching a fully operational facility.We will present STG’s partners and a cooperation model based on a single responsible partner who coordinates the entire investment process. Special attention will also be given to tax and financial advisory, including business structure planning, cost optimization, investment financing, and solutions that enhance the safety and profitability of the clinic from the very beginning of its operation.

Platelet-derived exosomes – their isolation, biological characteristics, and potential for clinical application in regenerative and aesthetic medicine. The lecture will discuss the mechanisms of action, the significance of extracellular vesicles in intercellular communication, and their role in repair and regenerative processes. The lecture will also present current trends and practical applications of platelet-derived exosomes in modern therapies.

This lecture introduces the STG brand as a new, integrated model for delivering medical and aesthetic medicine investments—from the initial business concept to launching a fully operational clinic. We will present the STG partner team, their competencies, and a collaboration model that eliminates chaos, risks, and costs associated with fragmented project management. The presentation will also outline the “single responsible partner” approach for investors—covering property acquisition (premises or land), design, construction, equipment, financing, IT, tax advisory, and all other essential elements required to launch and successfully operate a clinic.

The lecture presents the STG brand as an integrated model for delivering medical investments—from the initial idea and business analysis to launching a fully operational clinic.The STG partnership model will be discussed, enabling investors to go through the entire process with one responsible team—from location selection, design, and construction, to equipment, IT, financing, and tax advisory.Special attention will be given to the role of the Clinic Advisor in the process of creating and developing clinics. We will demonstrate how to build a profitable business model at the planning stage, including pricing strategy, service structure, sales and patient service processes, and KPIs that enable sustainable and predictable growth. The lecture will also cover the most common mistakes made by owners of new facilities, as well as solutions that increase revenue and operational security from the very first months of operation.